Adicet Bio, Inc. · LS:A41X5V
Adicet Bio, Inc. shareholders
As of Sep 30, 2026, 52 institutions reported holding Adicet Bio, Inc., 61.5% of its shares. Largest: Ra Capital Management, L.P., Orbimed Advisors LLC and Franklin Templeton. New holders, exits, insiders and big stakes, each with its filing.
Shareholders
Institutions
| Holder | Shares | Of the company | Value | As of |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 933K | 10.0% | US$6.66M | Sep 30, 2026 |
| Orbimed Advisors LLC | 845K | 9.0% | US$6.03M | Sep 30, 2026 |
| Franklin Templeton | 724K | 7.7% | US$2.24M | Sep 30, 2026 |
| Vanguard | 419K | 4.5% | US$2.99M | Sep 30, 2026 |
| Citadel | 280K | 3.0% | US$2M | Sep 30, 2026 |
| Renaissance Technologies | 215K | 2.3% | US$1.53M | Sep 30, 2026 |
| Alyeska Investment Group, L.P. | 204K | 2.2% | US$1.46M | Sep 30, 2026 |
| Adage Capital Partners Gp, L.L.C. | 193K | 2.1% | US$1.38M | Sep 30, 2026 |
| Schonfeld Strategic Advisors LLC | 189K | 2.0% | US$1.35M | Sep 30, 2026 |
| Stonepine Capital Management, LLC | 188K | 2.0% | US$1.34M | Sep 30, 2026 |
| Carlyle Group Inc. | 184K | 2.0% | US$1.32M | Sep 30, 2026 |
| Acadian Asset Management LLC | 171K | 1.8% | US$1.22M | Sep 30, 2026 |
| UBS | 118K | 1.3% | US$844K | Sep 30, 2026 |
| DAFNA Capital Management LLC | 93,812 | 1.0% | US$670K | Sep 30, 2026 |
| Trexquant Investment LP | 89,813 | 0.96% | US$641K | Sep 30, 2026 |
| Bridgeway Capital Management, LLC | 85,959 | 0.92% | US$614K | Sep 30, 2026 |
| Geode Capital | 84,847 | 0.91% | US$606K | Sep 30, 2026 |
| Two Sigma | 72,915 | 0.78% | US$521K | Sep 30, 2026 |
| Marshall Wace, LLP | 69,235 | 0.74% | US$494K | Sep 30, 2026 |
| Rangeley Capital, LLC | 64,000 | 0.68% | US$457K | Sep 30, 2026 |
| Burkehill Global Management, LP | 62,500 | 0.67% | US$446K | Sep 30, 2026 |
| BlackRock | 61,024 | 0.65% | US$436K | Sep 30, 2026 |
| Regeneron Pharmaceuticals, Inc. | 60,511 | 0.65% | US$432K | Sep 30, 2026 |
| Verdad Advisers, LP | 47,546 | 0.51% | US$339K | Sep 30, 2026 |
| Dimensional | 38,138 | 0.41% | US$272K | Sep 30, 2026 |
| State Street | 36,222 | 0.39% | US$259K | Sep 30, 2026 |
| RBF Capital, LLC | 36,082 | 0.39% | US$258K | Sep 30, 2026 |
| Jane Street | 25,980 | 0.28% | US$185K | Sep 30, 2026 |
| Prelude Capital Management, LLC | 24,862 | 0.27% | US$178K | Sep 30, 2026 |
| Connor, Clark & Lunn Investment Management Ltd. | 23,308 | 0.25% | US$166K | Sep 30, 2026 |
| Johnson & Johnson | 22,779 | 0.24% | US$163K | Sep 30, 2026 |
| Northern Trust | 18,436 | 0.20% | US$132K | Sep 30, 2026 |
| Engineers Gate Manager LP | 12,950 | 0.14% | US$92,463 | Sep 30, 2026 |
| Susquehanna | 12,942 | 0.14% | US$92,406 | Sep 30, 2026 |
| Vontobel Holding Ltd. | 12,775 | 0.14% | US$91,214 | Sep 30, 2026 |
| Occudo Quantitative Strategies LP | 12,310 | 0.13% | US$87,893 | Sep 30, 2026 |
| Morgan Stanley | 10,836 | 0.12% | US$77,370 | Sep 30, 2026 |
| Arax Advisory Partners | 6,001 | 0.06% | US$42,845 | Sep 30, 2026 |
| Citigroup Inc | 4,721 | 0.05% | US$33,708 | Sep 30, 2026 |
| BNP Paribas | 3,573 | 0.04% | US$25,511 | Sep 30, 2026 |
| RBC | 1,988 | 0.02% | US$14,000 | Sep 30, 2026 |
| Tower Research Capital LLC (TRC) | 1,038 | 0.01% | US$7,412 | Sep 30, 2026 |
| Simplex Trading, LLC | 934 | <0.01% | US$6,668 | Sep 30, 2026 |
| Avion Wealth | 246 | <0.01% | US$1,000 | Sep 30, 2026 |
| JPMorgan | 201 | <0.01% | US$1,373 | Sep 30, 2026 |
| Rialto Wealth Management, LLC | 61 | <0.01% | US$436 | Sep 30, 2026 |
| SBI Securities Co., Ltd. | 35 | <0.01% | US$250 | Sep 30, 2026 |
| Caitong International Asset Management Co., Ltd | 28 | <0.01% | US$200 | Sep 30, 2026 |
| National Bank Of Canada | 17 | <0.01% | US$121 | Sep 30, 2026 |
| Barclays | 3 | <0.01% | US$21 | Sep 30, 2026 |
This page holds 50 of 52 holders.
Funds
| Holder | Shares | Of the company | Value | As of |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 241K | 2.6% | US$2.08M | Jun 30, 2026 |
| Franklin Biotechnology Discovery Fund | 225K | 2.4% | US$2.05M | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 98,912 | 1.1% | US$855K | Jun 30, 2026 |
| Ultra-Small Company Fund | 85,959 | 0.92% | US$743K | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 47,760 | 0.51% | US$445K | May 31, 2026 |
| iShares Micro-Cap ETF | 23,940 | 0.26% | US$207K | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 17,363 | 0.19% | US$162K | May 31, 2026 |
| Dimensional U.S. Small Cap ETF | 14,520 | 0.16% | US$132K | Jul 31, 2026 |
| U.S. Micro Cap Portfolio | 14,264 | 0.15% | US$130K | Jul 31, 2026 |
| Fidelity Series Total Market Index Fund | 12,361 | 0.13% | US$115K | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 4,839 | 0.05% | US$45,051 | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 2,584 | 0.03% | US$22,326 | Jun 30, 2026 |
| 1290 VT Micro Cap Portfolio | 1,601 | 0.02% | US$13,833 | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 1,489 | 0.02% | US$12,865 | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 786 | <0.01% | US$6,791 | Jun 30, 2026 |
Big stakes
| Stake | Stake | Shares | Date | Filing |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 9.90% | 935K | Jun 30, 2026 | Schedule 13G |
| Franklin Resources Inc | 7.70% | 724K | Sep 30, 2026 | Schedule 13G |
| Zedek Daniel Clayton | 5.40% | 502K | Oct 19, 2026 | Schedule 13G |